Effects of pergolide on severe sleep bruxism in a patient experiencing oral implant failure

Journal of Oral Rehabilitation

Volumn 34, Issue 5, 2007, Pages 317-322

  Van Der Zaag, J ^a   Lobbezoo, F ^a   Van Der Avoort, P G G L ^a   Wicks, D J ^b   Hamburger, H L ^b   Naeije, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Case report; Occlusal stabilization splint; Pergolide; Polysomnography; Sleep bruxism

Indexed keywords

DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; PERGOLIDE;

ARTICLE; BRUXISM; CASE REPORT; DENTAL EQUIPMENT; DENTAL SURGERY; DRUG COMBINATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PROSTHESIS FAILURE; TABLET; TREATMENT OUTCOME;

DENTAL RESTORATION FAILURE; DOMPERIDONE; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; OCCLUSAL SPLINTS; PERGOLIDE; POLYSOMNOGRAPHY; PROSTHESIS FAILURE; SLEEP BRUXISM; TABLETS; TREATMENT OUTCOME;

EID: 33847342894     PISSN: 0305182X     EISSN: 13652842     Source Type: Journal    
DOI: 10.1111/j.1365-2842.2006.01651.x     Document Type: Article

References (33)

1. American Academy of Sleep Medicine. International classification of sleep disorders, revised: Diagnostic and coding manual. Chicago, IL: American Academy of Sleep Medicine, 2001.
2. Okeson JP. Orofacial pain. Guidelines for assessment, diagnosis, and management. Chicago, IL: Quintessence Publishing Co, Inc, 1996.
3. The Glossary of Prosthodontic Terms. J Prosthet Dent. 2005;94:10-92.
4. Hugh JD. Harlan J. Nocturnal bruxism and temporomandibular disorders. Adv Neurol. 1988;49:329-341.
5. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. Eur J Oral Sci. 1998;106:721-764.
6. Lobbezoo F, Lavigne GJ. Do bruxism and temporomandibular disorders have a cause-and-effect relationship? J Orofacial Pain. 1997;11:15-23.
7. Lobbezoo F, Brouwers JEIG, Cune MS, Naeije M. Dental implants in patients with bruxing habits. J Oral Rehabil. 2006;33:293-300.
8. Lobbezoo F, van der Zaag J, Naeije M. Bruxism: its multiple causes and its effects on dental implants. An updated review. J Oral Rehabil. 2006;33:152-159.
9. Lavigne GJ, Goulet JP, Zuconni M, Morisson F, Lobbezoo F. Sleep disorders and the dental patient: a review of diagnosis, pathophysiology and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999:88:257-272.
10. Dao TTT, Lavigne GJ. Oral splints: the crutches for temporomandibular disorders and bruxism? Crit. Rev Oral Biol Med. 1998;9:345-361.
11. Winocur E, Gavish A, Voikovitch M, Emodi-Perlman A, Eli I. Drugs and bruxism: a critical review. J Orofac Pain. 2003;17:99-111.
12. Lavigne GJ, Rompré PH, Montplaisir JY. Sleep bruxism: validity of clinical research diagnostic criteria in a controlled polysomnographic study, J Dent Res. 1996;75;546-552.
13. van der Zaag J, Lobbezoo F, Wicks DJ, Visscher CM, Hamburger HL, Naeije M. Placebo-controlled assessment of the efficacy of occlusal stabilization splints on sleep bruxism. J Orofacial Pain. 2005;19:151-158.
14. DworkIn SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6:301-355.
15. Lobbezoo F, van Selms MKA, John MT, Huggins K, Ohrbach R, Visscher CM, van der Zaag J, van der Meulen MJ, Naeije M, Dworkin SF. Use of the Research Diagnostic Criteria for Temporomandibular Disorders for multinational research: translation efforts and reliability assessments in The Netherlands. J Orofacial Pain. 2005;19:301-308.
16. Lobbezoo F, Naeije M. A reliability study of clinical tooth wear measurements. J Prosthet Dent. 2001;86:597-602.
17. van der Meulen MJ, Lobbezoo F, Aartman IHA, Naeije M. Self-reported oral parafunctions and TMD pain intensity. J Orofacial Pain. 2006;20:31-35.
18. Rechtschaffen A, Kales A. A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. Los Angeles, CA: UCLA Brain Information Service/Brain Research Institute, 1968.
19. Rasmussen C, Nielsen KD, Arima T, Svensson P, Rössel P, Drewes AM, Arendt-Nielsen L. An automatic system for selective and standardized sleep deprivation. J Sleep Res. 1998;7:221.
20. Clarke CE, Guttman M. Dopamine agonist monotherapy in Parkinson's disease, Lancet. 2002;360;1767-1769.
21. Cornella CL. Restless legs syndrome. Treatment with dopaminergic agents. Neurology. 2002;58:S87-S92.
22. Lobbezoo F, Soucy JP, Montplaisir JY, Lavigne GJ. Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine- 123-iodobenzamide and single photon emission computed tomography. J Dent. Res. 1996;75:1804-1810.
23. Lobbezoo F, Naeije M. Bruxism is mainly regulated centrally, not peripherally. J Oral Rehabil. 2001;28:1085-1091.
24. Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY. The effect of the catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial. Movement Disord. 1997;12:73-78.
25. Lobbezoo F, Soucy JP, Hartman NG, Montplaisir JY, Lavigne GJ. Effects of the dopamine D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials. J Dent Res. 1997;76:1611-1615.
26. Lavigne GJ, Soucy JP, Lobbezoo F, Manzini C, Blanchet PJ, Montplaisir JY. Double Blind, crossover, placebo-controlled trial with bromocriptine in patients with sleep bruxism. Clin Neuropharmacol. 2001;24:145-149.
27. Emillen G, Maloteaux JM, Geurts M, Hoogenberg K, Cragg S. Dopamine receptors - physiological understanding to therapeutic intervention potential. Pharmacol Ther. 1999;84: 133-156.
28. Dhawan V, Medcalf P, Stegie F, Jackson G, Basu S, Luce P, Odin P, Ray Chaudhuri K. Retrospective evaluation of cardiopulmonary fibroeic side effects in symptomatic patients from a group of 234 Parkinson's disease patients treated with cabergoline. J Neural Transm. 2005; 112:661-668.
29. Lavigne GJ, Guitard F, Rompré PH, Montplaisir JY. Variability in sleep bruxism activity over time. J Sleep Res. 2001;10:237-244.
30. Itoh H, Katagiri F, Ikawa K, Takeyama M. Effects of domperidone on human plasma levels of motilin, somatostatin, gastrin, adrenocorticotropic hormone and cortisol. Biol Pharm Bull. 2005;28:1752-1756.
31. Ohayon MM, Li KK, Guilleminault C. Risk factors for sleep bruxism in the general population. Chest. 2001;119:53-61.
32. Ahlberg J, Savolainen A, Rantala M, Lindholm H. Kononen M. Reported bruxism and biopsychosocial symptoms: a longitudinal study. Community Dent Oral Epidemiol. 2004;32:307-311.
33. Berglundh T, Persson L, Klinge B. A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol. 2002;29:197-212.